Sanofi’s Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopeniaNovel treatment targets BTK through multi-immune ...

The Founder and Chief Executive Officer of CrimsonBow, Ms Timi Edwin, gave the commendation at the initiative’s ...

Sanofi's Wayrilz approved in the EU as the first BTK inhibitor to treat immune thrombocytopenia Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP ...

Sanofi’s Wayrilz, the first BTK inhibitor to treat immune thrombocytopenia gets European approval: Paris Saturday, December 27, 2025, 12:00 Hrs [IST] Sanofi, an R&D driven, AI-p ...

Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...

ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD).

Piper Sandler boosted its target price to $23 per share from $16. ・Wainwright increased its price target to $25 from $18, noting a clear dose-response in fetal hemoglobin (HbF) and a strong ...

Application error: a client-side exception has occurred (see the browser console for more information).

Strictly Come Dancing fans believe they've 'worked out' Tess Daly and Claudia Winkleman's replacement as a huge BBC star has quit their job. Tess and Claudia shocked fans in October when they ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

Claims that Lyme disease was developed as a military bioweapon and escaped from a government lab are flatly contradicted by decades of scientific evidence -- despite what federal regulators have ...